Digital4Pharma

💡 Knowledge becomes valuable when it can be applied.

👉 The workshops at Digital4Pharma 2026 brought together professionals from across healthcare and pharma to explore today's most relevant topics, from Artificial Intelligence and customer engagement to experiential design, disease awareness, AI-powered marketing, digital visibility and regulatory readiness.

Designed to be practical, interactive and forward-looking, each session offered fresh perspectives, real-world insights and meaningful discussions on the challenges and opportunities shaping the future of healthcare.

A sincere thank you 🙏 to all our workshop leaders for sharing their expertise and to every participant who contributed to the conversations.
Learning doesn't end when the workshop is over; it continues through every new idea we put into practice.

💡 Artificial Intelligence is no longer a future ambition.
It is already transforming the way healthcare organizations learn, engage, communicate and make decisions.

👉 The second Business Cases session at Digital4Pharma 2026 highlighted how AI is moving from experimentation to implementation, with real-world applications that are already creating value across the healthcare ecosystem.
From AI Twins and intelligent engagement to experiential learning and AI-powered decision-making, the discussion demonstrated that successful AI adoption is driven not only by technology, but by strategy, collaboration and trust.

Thank you 🙏 to everyone who shared their expertise and inspired the conversation around the next generation of healthcare innovation.
The conversation continues.

💡Innovation creates value only when it improves people's experiences.

👉The first Business Cases session at Digital4Pharma 2026 showcased how leading healthcare organizations are transforming ideas into real-world impact through experience design, digital engagement, personalization, and collaboration.

From immersive technologies and healthcare ecosystems to patient journey design and real-time engagement, each case demonstrated that meaningful innovation starts with understanding people and building trust.

Thank you 🙏to everyone who shared their expertise and contributed to an inspiring exchange of ideas and practical experience.
The conversation continues.

💡Every meaningful collaboration starts with a shared vision.
As healthcare enters a new era shaped by AI, data and digital innovation, the conversation is no longer about technology alone. It is about creating the conditions for trust.

At Digital4Pharma 2026, Myron Flouris, Head of Steering Committee at AI Catalyst, will deliver the opening keynote of the panel discussion:
𝗦𝗵𝗮𝗽𝗶𝗻𝗴 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝗶𝗻 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗳𝗼𝗿 𝗮𝗰𝗰𝗲𝘀𝘀 𝘁𝗼 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆, 𝗺𝗼𝗱𝗲𝗹𝘀 𝗮𝗻𝗱 𝗱𝗮𝘁𝗮.

👉With more than two decades of experience across business development, innovation, financial services and digital transformation, Myron has worked with leading international consulting firms and public sector organizations, contributing to large-scale transformation initiatives and innovation strategies. Today, as Head of the Steering Committee of AI Catalyst, he actively supports the development of Greece's AI ecosystem.
His opening remarks will set the stage for a discussion on how collaboration between industry, academia, government and healthcare stakeholders can accelerate innovation and create lasting impact.

📍 Digital4Pharma 2026 | TRUSTFORMATION
🔗 Explore the agenda:
https://get2work.eu/digital4pharma-2026-trustformation/

💡Building the future of healthcare requires more than technology.
It requires collaboration between industry, policy, research, healthcare providers, and patients.

At Digital4Pharma 2026, leading voices from across the healthcare ecosystem come together to discuss:
𝗦𝗵𝗮𝗽𝗶𝗻𝗴 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝗶𝗻 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗳𝗼𝗿 𝗮𝗰𝗰𝗲𝘀𝘀 𝘁𝗼 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆, 𝗺𝗼𝗱𝗲𝗹𝘀 𝗮𝗻𝗱 𝗱𝗮𝘁𝗮.

👉Joining the panel is Labrina Barmpetaki, President of the Board & Managing Director of AbbVie Greece, Cyprus & Malta,
A' Vice President and President of Pharmaceutical Committee of the American-Hellenic Chamber of Commerce.
An accomplished international executive with extensive experience across the pharmaceutical, biotechnology, and consulting sectors, Labrina has led strategy and business transformation initiatives in more than 20 countries. Her leadership combines deep industry expertise with a strong commitment to innovation, collaboration, and advancing healthcare outcomes.

Join us on July 8 for a discussion on how cross-sector collaboration can accelerate innovation and shape a more connected, trusted and sustainable healthcare ecosystem.

📍 Digital4Pharma 2026 | TRUSTFORMATION
🔗 Explore the agenda:
https://get2work.eu/digital4pharma-2026-trustformation/

💡Building the future of healthcare requires more than technology.
It requires collaboration between industry, policy, research, healthcare providers and patients.

At Digital4Pharma 2026, leading voices from across the healthcare ecosystem come together to discuss: 𝗦𝗵𝗮𝗽𝗶𝗻𝗴 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝗶𝗻 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗳𝗼𝗿 𝗮𝗰𝗰𝗲𝘀𝘀 𝘁𝗼 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆, 𝗺𝗼𝗱𝗲𝗹𝘀 𝗮𝗻𝗱 𝗱𝗮𝘁𝗮.

👉Joining the panel is Markos Ollandezos, Director of Scientific Affairs at the Hellenic Association of Pharmaceutical Companies (PEF) and Partner at Health Hub.
A health economist with extensive experience in health policy and pharmaceutical economics, Markos has been actively involved in shaping market access strategies, healthcare policy and industry collaboration in Greece and across Europe. Alongside his role at PEF, he contributes to academia through teaching and research, bringing together scientific knowledge, policy expertise and practical industry experience.
Join us on July 8 for a discussion on the partnerships, policies and innovation needed to build a more connected and data-driven healthcare ecosystem.

📍 Digital4Pharma 2026 | TRUSTFORMATION
🔗 Explore the agenda:
https://get2work.eu/digital4pharma-2026-trustformation/